| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA427504
Max Phase: Preclinical
Molecular Formula: C20H25ClN4O2S
Molecular Weight: 420.97
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(Nc1ncc(Cl)s1)N(CC1CCCC1)c1ccc(N2CCOCC2)cc1
Standard InChI: InChI=1S/C20H25ClN4O2S/c21-18-13-22-19(28-18)23-20(26)25(14-15-3-1-2-4-15)17-7-5-16(6-8-17)24-9-11-27-12-10-24/h5-8,13,15H,1-4,9-12,14H2,(H,22,23,26)
Standard InChI Key: DFZMWONSRZUPSB-UHFFFAOYSA-N
Associated Targets(non-human)
Hexokinase type IV 278 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 420.97 | Molecular Weight (Monoisotopic): 420.1387 | AlogP: 4.86 | #Rotatable Bonds: 5 |
| Polar Surface Area: 57.70 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.28 | CX Basic pKa: 0.85 | CX LogP: 4.66 | CX LogD: 4.32 |
| Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.75 | Np Likeness Score: -1.95 |
References
| 1. Castelhano AL, Dong H, Fyfe MC, Gardner LS, Kamikozawa Y, Kurabayashi S, Nawano M, Ohashi R, Procter MJ, Qiu L, Rasamison CM, Schofield KL, Shah VK, Ueta K, Williams GM, Witter D, Yasuda K.. (2005) Glucokinase-activating ureas., 15 (5): [PMID:15713416] [10.1016/j.bmcl.2004.12.083] |
Source
Source(1):